Pain Therapeutics’ Remoxy Approval Hinges On REMS; FDA Unsure If Drug Is Abuse-Resistant

FDA’s Anesthetic and Life Support Drugs and Drug Safety and Risk Management Advisory Committees will discuss whether the proposed REMS can adequately determine abuse of the opioid.